Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis
Status:
Unknown status
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The study´s purpose is to investigate the effect of beta blockade or aldosterone antagonist
therapy on oxygenation, peripheral and cardiac hemodynamics and humoral systems, in patients
with liver cirrhosis.